Financials
- Market Capitalization 13.94 B
- Employee 1 077
- Founded 1994
- CEO Michael M. Morrissey
- Website www.exelixis.com
- Headquarter Delaware, United States
- FIGI BBG000BQ4WF8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
14.56
Relación precio/flujo de caja
5.14
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 662 | ASND Ascendis Pharma A/S - American Depositary Shares | 262.83 USD | -1.03% | -3.74% | +17.60% | +28.16% | 16.29 B USD | ||
| 708 | JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 238.88 USD | +0.35% | -2.87% | +3.47% | +70.63% | 14.99 B USD | ||
| 802 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 538.70 USD | +0.34% | -2.26% | +6.65% | +27.17% | 12.42 B USD | ||
| 816 | AXSM Axsome Therapeutics, Inc. - Common Stock | 232.72 USD | -1.08% | -5.95% | -8.75% | +78.74% | 11.98 B USD |